The Latest Breaking News from Eli Lilly

The S&P 500 Index ($SPX ) (SPY ) today is up +0.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. US stocks are trading higher today after US weekly initial unemployment claims fell more...

Stock Market Today: The Dow Jones rallied 500 points Thursday on a big drop in weekly jobless claims. Dutch Bros plunged on earnings.

The S&P 500 is down "only" 8.2% since its July 16 high. So why does the drop feel so bad?

Recession fears are gripping the market. Warren Buffett's Berkshire halved its Apple stake. Nvidia reportedly has delayed its next AI chip.

Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.

Their strong fundamentals, brand strength, and drive to succeed could propel their stock higher.

The pharmaceutical industry’s long-term growth is fueled by a surge in demand for personalized medicine, rising R&D initiatives, and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid pharma stocks, Eli Lilly (LLY), Bristol-Myers (BMY), and Merck & Co. (MRK), which look poised for blockbuster…

As the stock market evolves, leading S&P 500 stocks like Eli Lilly and Company (LLY), Howmet Aerospace (HWM), and NetApp (NTAP) are well-positioned to capitalize on current market conditions and climb higher. Read on….

Roche is working on bringing its weight-loss medications to patients "faster than anticipated,” making it yet another contender in the weight-loss drug market.